Effects of yucca extract (YE) on feed efficiency, immune and antioxidative function in
Infectious diseases, particularly bovine respiratory disease (BRD) and neonatal calf diarrhea (NCD), are prevalent in calves. Efficient health-monitoring tools to identify such diseases on time are lacking. Common practice (i.e., health checks) often identifies sick calves at a late stage of disease or not at all. Sensor technology enables the automatic and continuous monitoring of calf physiology or behavior, potentially offering timely and precise detection of sick calves. A systematic overview of automated disease detection in calves is still lacking. The objectives of this literature review were hence: to investigate previously applied sensor validation methods used in the context of calf health, to identify sensors used on calves, the parameters these sensors monitor, and the statistical tools applied to identify diseases, to explore potential research gaps and to point to future research opportunities. To achieve these objectives, systematic literature searches were conducted. We defined four stages in the development of health-monitoring systems: (1) sensor technique, (2) data interpretation, (3) information integration, and (4) decision support. Fifty-four articles were included (stage one: 26; stage two: 19; stage three: 9; and stage four: 0). Common parameters that assess the performance of these systems are sensitivity, specificity, accuracy, precision, and negative predictive value. Gold standards that typically assess these parameters include manual measurement and manual health-assessment protocols. At stage one, automatic feeding stations, accelerometers, infrared thermography cameras, microphones, and 3-D cameras are accurate in screening behavior and physiology in calves. At stage two, changes in feeding behaviors, lying, activity, or body temperature corresponded to changes in health status, and point to health issues earlier than manual health checks. At stage three, accelerometers, thermometers, and automatic feeding stations have been integrated into one system that was shown to be able to successfully detect diseases in calves, including BRD and NCD. We discuss these findings, look into potentials at stage four, and touch upon the topic of resilience, whereby health-monitoring system might be used to detect low resilience (i.e., prone to disease but clinically healthy calves), promoting further improvements in calf health and welfare.
The present study was conducted to investigate the effect of Artemisia argyi aqueous extract (AAE) on antioxidant indexes in the small intestine. A total of 192 Arbor Acre broiler chickens (one-day-old) were randomly divided into 4 treatments with 6 replicates of 8 chickens. These 4 diets were formulated by adding 0, 500, 1,000 and 2,000 mg/kg AAE to the basal diet. The results showed as follows: 1) compared with the control, the total antioxidant capacity (T-AOC) in ileum for the 2,000 mg/kg treatment group was significantly increased at 21 days of age (P < 0.05); the T-AOC levels in jejunum and ileum were significantly increased in broilers supplemented with 500 mg/kg AAE at 42 days of age (P < 0.05), and the T-AOC levels in jejunum and ileum were significantly improved in 1,000 mg/kg treatment group (P < 0.01). 2) At 21 days of age, supplementation of 500 mg/kg AAE significantly increased the catalase (CAT) activity of small intestine, and the glutathione peroxidase (GSH-Px) activity of jejunum was improved (P < 0.01), meanwhile, the GSH-Px activity of duodenum and the total superoxide dismutase (T-SOD) activity of duodenum and jejunum were significantly higher than those of the control group (P < 0.05); supplementation of 1,000 mg/kg AAE significantly increased the CAT activity of duodenum and ileum and the GSH-Px activity of duodenum and jejunum (P < 0.05), and the ileum GSH-Px activity was significantly increased (P < 0.01); supplementation of 2,000 mg/kg AAE significantly increased the CAT activity of duodenum and ileum (P < 0.05). At 42 days of age, supplementation of 500 mg/kg AAE significantly increased the GSH-Px activity of ileum and the T-SOD activity of duodenum (P < 0.05), meanwhile, the T-SOD activity of jejunum was significantly increased (P < 0.01); supplementation of 1,000 mg/kg AAE significantly increased the CAT activity of jejunum and the T-SOD activity of ileum (P < 0.01), and the GSH-Px activity of jejunum was significantly increased (P < 0.05); supplementation of 2,000 mg/kg AAE significantly increased the T-SOD activity of ileum (P < 0.05), but significantly decreased the CAT activity of ileum and the GSH-Px activity of jejunum (P < 0.05). 3) The malondialdehyde (MDA) levels of 3 AAE supplementation groups were significantly decreased at 21 and 42 days of age (P < 0.05). The results suggested that dietary supplementation with AAE could improve the antioxidative capacity of small intestine in broilers.
Dietary Yucca schidigera extract (YSE) could enhance immune function in broilers, which was attributed primarily to its saponin components. However, YSE also contains phenolic compounds which possess antioxidant ability. This study tested the effects of YSE on growth performance of broilers, its antioxidative enzyme activities and corresponding gene expressions in the small intestine. A total of 128 15‐day‐old broilers were randomly assigned to 4 treatments: corn‐soya bean meal as the basal control diet or the basal diet containing either 100, 200 or 300 mg/kg of YSE. Each treatment consisted of four replicate pens with eight broilers per pen. The experiment lasted 28 days which was divided into a grower period (day: 15–28) and a finisher period (day: 29–42). On day 28 and day 42 body weight (BW), feed intake (FI) and feed conversion rate (FCR) were recorded. Duodenum, jejunum and ileum were collected to analyse superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) activities, malondialdehyde (MDA) concentrations, total antioxidant capacity (T‐AOC) and gene expressions of SOD, CAT, GPx. The results showed that during the grower period a diet including 100 mg/kg YSE improved CAT capacity in the ileum, tended to increase activities of GPx in the duodenum, and further showed enhancing tendencies in SOD and GPx abilities in ileum. Gene expressions of CAT, SOD and GPx in the ileum tended to upregulate at 100 mg/kg YSE level. In the finisher period and over the whole period, all YSE groups had a reduced FI compared to the control group without compromising BW; 100 and 200 mg/kg YSE significantly improved FCR. In conclusion, the improved growth performance of broilers during the finisher period may be due to enhanced antioxidative ability in the grower period with YSE supplementation. This study provided evidence of using YSE as an additive to enhance growth in broilers.
This study investigated the effects of Artemisia argyi extract (AAE) on broilers challenged with lipopolysaccharide (LPS). A total of 96 Arbour Acres broilers (1-d-old) were assigned to a 2 Â 2 factorial arrangement with two dietary treatments (AAE at 0 or 1000 mg/kg) and two immunological challenge treatments (saline or LPS). On d 14, 16, 18 and 20, the broilers were injected intra-abdominally with LPS solution at 500 lg/kg of body weight or an equivalent amount of sterile saline. Blood, liver, spleen and small intestine were collected on day 21. The increased relative weights of the thymus and spleen induced by LPS were significantly decreased by AAE supplementation. The level of serum nitric oxide (NO) and the activity of inducible NO synthase (iNOS) were significantly compromised by AAE inclusion. Dietary AAE significantly inhibited the mRNA expression of toll-like receptor 4 (TLR4), myeloid differentiation factor 88, nuclear factorkappa B (NF-jB) and iNOS in the different tissues of LPS-challenged broilers. The AAE supplementation tended to increase the levels of serum GSH-Px and CAT, but significantly reduced the level of serum malondialdehyde (MDA). Collectively, feeding AAE to LPS-challenged broilers could decrease serum NO level, maintain the relative weight of internal organs, enhance the antioxidant capacity, and inhibit TLR4/NF-jB signalling pathway at the transcriptional level. HIGHLIGHTS AAE inclusion significantly inhibited the serum NO level, and the activity of iNOS induced by LPS. AAE supplementation tended to increase the levels of serum GSH-Px and CAT, but significantly reduced the level of serum MDA. Feeding AAE to the LPS-challenged broilers reduced the expression of TLR4, MyD88 and NF-jB in the liver, spleen and small intestine.
The present experiment was conducted to investigate the effects of water extract of Artemisia ordosica (WEAO) on growth performance, antioxidant capability and immune response in weanling piglets. Seventy‐two 28‐day‐old weanling piglets were randomly allocated into four treatments with six replicate pens per treatment and three piglets per pen (n = 18). These four treatment diets were formulated by adding 0, 250, 500 and 750 mg/kg WEAO to the basal diet. The experiment lasted for 28 days. Body weight and feed intake were measured. Blood samples were collected to determine immune and antioxidative parameters. The experimental results showed that WEAO supplementation improved the apparent nutrient digestibility of piglets in a linear or quadratic dose‐dependent manner. In addition, dietary WEAO quadratically increased serum concentrations of cytokines interleukin (IL)‐1, IL‐4, tumour necrosis factor (TNF)‐α, soluble surface antigen CD8 (sCD8), immunoglobulins (Ig)‐A and linearly increased serum concentrations of IL‐2, IL‐6, IgG, IgM. Furthermore, dietary WEAO linearly or quadratically decreased serum concentrations of malondialdehyde but quadratically increased activities of antioxidant enzymes and total antioxidative capacity. These results suggested that WEAO may prove useful as a natural phytogenic feed additive with antioxidative potential and could be incorporated into diets of piglets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.